About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

LOGIN
My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Human Gene Therapy

Editor-in-Chief: James M. Wilson, MD, PhD
Deputy Editor: George Dickson, BSc, PhD
Human Gene Therapy Editor: Mark A. Kay, MD, PhD
Methods Editor: Thierry VandenDriessche, PhD
Clinical Development Editor: Barry J. Byrne, MD, PhD

ISSN: 1043-0342 • Published 22 issues annually • Online ISSN: 1557-7422

Current Volume: 25

Latest Impact Factor* is 4.019

*2012 Journal Citation Reports® published by Thomson Reuters, 2013

Open Access Options for this Peer-Reviewed Journal


Choose Liebert Open Access Option!

Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) Option.

Your investment guarantees:

  • Immediate, unrestricted global access in 170 countries
  • Maximum visibility for increased readers, citations, and downloads
  • Targeted email announcement highlighting your article to thousands of thought-leaders in your field
  • Rapid, rigorous peer-review and editorial attention
  • Fast Track online-ahead-of-print publication
  • Immediate upload to PubMed Central and other internationally recognized repositories*
  • Recognition on online Table of Contents with exclusive OA icon
  • Compliance with OA funding mandates with no embargo period
  • Complimentary one-year membership in AuthorCite®, the author services platform exclusively licensed by Mary Ann Liebert, Inc. that delivers the tools you need to maximize your professional impact.

These valuable benefits are included with a one-time article processing charge (APC). APC charge varies based on journal, membership, and subsequent submissions.

Contact openaccess@liebertpub.com for questions on article Open Access options. 

 *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.

View Features and Impact! 


Is your Institution a member of the Liebert Author Advocacy Program?

The Liebert Author Advocacy Program (LAAP) provides valuable membership benefits for OA publication to institutional and funding organizations, and supports global funding mandates.  Authors who are affiliated with LAAP member institutions receive all the valuable benefits of Liebert OA article publication, and more.

For details, and to recommend institutional membership visit: www.authoradvocacy.com or contact laap@liebertpub.com 

 

 

 

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Tissue Engineering, Parts A, B, & C

    Tissue Engineering, Parts A, B, & C

    The preeminent, biomedical journal bringing together the principles of engineering and life sciences to advance the field with cutting-edge research and applications on all aspects of tissue growth and regeneration.

    Nucleic Acid Therapeutics

    Nucleic Acid Therapeutics

    formerly Oligonucleotides

    Focuses on cutting-edge research and applications to find and examine new approaches using nucleic acids in therapeutics including oligonucleotides, gene modification, aptamers, RNA nanoparticles, ribozymes, and more.

    Stem Cells and Development

    Stem Cells and Development

    Globally recognized as the trusted source for critical, even controversial coverage of emerging hypotheses and novel findings on stem cells of all tissue types and their potential therapeutic applications.

    Zebrafish

    Zebrafish

    Solely focused on disseminating the latest cutting-edge advances in the zebrafish as a model organism for the study of vertebrate development, with attention to other aquarium species including medaka, Fugu, and Xiphophorus.

Browse All Publications »